AZİTROMİSİN COVİD-19 DA ETKİSİZ!
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Published:LANCET: September 04, 2020DOI:https://doi.org/10.1016/S0140-6736(20)31862-6
In patients with severe COVID-19, adding azithromycin to standard of care treatment (which included hydroxychloroquine) did not improve clinical outcomes. Our findings do not support the routine use of azithromycin in combination with hydroxychloroquine in patients with severe COVID-19.